Just some of the applications for our platforms

Immunology

Discovery of modulators of inflammation, innate immunity, and autoimmunity-based disorders.

Neuroinflammation

Developing compounds that target neuroinflammation and neurodegeneration.

Antibiotic Development

Development of biofilm-disrupting  compounds as well as novel classes of antibiotics.

Orphan Diseases

Developing compounds that target rare congenital disorders through targeting novel pathways.

Oncology

Developing compounds which target pathways that are selectively essential in cancer cells.

Membrane Proteins

Discovery of peptides that modulate the activity of membrane proteins (e.g. GPCRs, solute carrier SLC proteins, and ion channels).

  • Twitter
  • LinkedIn Social Icon

© 2020 by SyntheX

409 Illinois st, San Francisco, CA 94158